
Alzheimer's disease zzso an zzso progressive neurodegenerative disorder clinically characterized by memory loss and cognitive decline, is the leading cause of zzso in the elderly, leading invariably to death within zzso years after zzso In zzso zzso imaging with zzso zzso zzso zzso is allowing new insights into zzso zzso deposition in the brain, zzso research into the causes, diagnosis, and future treatment of zzso where zzso may play a zzso zzso zzso of zzso burden in the brain with PET has proven useful in the early and differential diagnosis of zzso showing significantly higher retention in zzso matter of zzso patients when compared with healthy controls zzso or patients with zzso lobe zzso zzso With the advent of new therapeutic strategies aimed at reducing zzso burden in the brain to potentially prevent or delay functional and irreversible cognitive loss, there is increased interest in developing agents that allow assessment of zzso burden in zzso A key aspect for zzso burden zzso is the application of zzso or zzso analyses to the kinetic data in order to obtain quantitative and zzso statements that allow comparison with other zzso groups, correlation with cognitive or biological zzso and selection, monitoring, and follow-up of individuals in disease zzso therapeutic zzso It is also a necessary step in the validation of simplified approaches that could be applied in routine clinical zzso With the availability of novel zzso imaging agents zzso with either zzso zzso 20 zzso or zzso zzso 110 zzso a description of different image acquisition approaches is zzso 

